EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery

Andrea Plaja iD, Iris Teruel, Maria Ochoa-de-Olza, Marc Cucurull iD, Álvaro Javier Arroyo, Beatriz Pardo, Irene Ortiz, Marta Gil-Martin, Josep María Piulats, Helena Pla iD, Claudia Fina, Anna Carbó iD und 6 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241411420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Andrea Plaja und 17 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Institut Català d'Oncologia (ICO)-Badalona, Badalona Applied Research Group in Oncology (BARGO), Institut d'Investigació…. Hauptthemen laut MEDLINE: Neutrophils, Ovarian Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite a multimodal radical treatment, mortality of advanced epithelial ovarian cancer (AEOC) remains high. Host-related factors, such as systemic inflammatory response and its interplay with the immune system, remain underexplored. We hypothesized that the prognostic impact of this response could vary between patients undergoing primary debulking surgery (PDS) and those undergoing interval debulking surgery (IDS). Therefore, we evaluated the outcomes of two surgical groups of newly diagnosed AEOC patients according to the neutrophil, monocyte and platelet to lymphocyte ratios (NLR, MLR, PLR), taking median ratio values as cutoffs. In the PDS group (n = 61), low NLR and PLR subgroups showed significantly better overall survival (not reached (NR) vs. 72.7 months, 95% confidence interval [CI]: 40.9–95.2, p = 0.019; and NR vs. 56.1 months, 95% CI: 40.9–95.2, p = 0.004, respectively) than those with high values. Similar results were observed in progression free survival. NLR and PLR-high values resulted in negative prognostic factors, adjusting for residual disease, BRCA1/2 status and stage (HR 2.48, 95% CI: 1.03–5.99, p = 0.043, and HR 2.91, 95% CI: 1.11–7.64, p = 0.03, respectively). In the IDS group (n = 85), ratios were not significant prognostic factors. We conclude that NLR and PLR may have prognostic value in the PDS setting, but none in IDS, suggesting that time of surgery can modulate the prognostic impact of baseline complete blood count (CBC).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeutrophilsOvarian NeoplasmsHumansFemaleCarcinoma, Ovarian EpithelialMonocytesBRCA1 ProteinPrognosisCytoreduction Surgical ProceduresRetrospective StudiesBRCA2 ProteinLymphocytes

Stichwörter der Autor:innen

inflammatory biomarkersmonocyte-to-lymphocyte rationeutrophil to lymphocyte ratioovarian cancerplatelet-to-lymphocyte ratioprognostictype of surgery

Substanzen

BRCA1 protein, humanBRCA1 ProteinBRCA2 protein, humanBRCA2 Protein

Autor:innen und Institutionen

  • Medical Oncology Department, Institut Català d'Oncologia (ICO)-Badalona, Badalona Applied Research Group in Oncology (BARGO), Institut d'Investigació Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.
  • Medical Oncology Department, Institut Català d'Oncologia (ICO)-L'Hospitalet, Hospital Duran i Reynals, Institut d'Investigació de Bellvitge (IDIBELL), 08908 Barcelona, Spain.
  • Medical Oncology Department, Institut Català d'Oncologia (ICO)-Girona, Girona Biomedical Research Institut d'Investigació Biomèdica de Girona (IDIBGi), 17007 Girona, Spain.
  • Obstetrics and Gynecologycal Department, Hospital Germans Trias i Pujol, 08916 Badalona, Spain.

ORCID-Profile: Andrea Plaja, Marc Cucurull, Helena Pla, Anna Carbó, Sergio Martínez-Román, Andrea González, Anna Esteve, Margarita Romeo

Zitieren

APA

Plaja, A., Teruel, I., Ochoa-de-Olza, M., Cucurull, M., Arroyo, Á. J., Pardo, B., Ortiz, I., Gil-Martin, M., Piulats, J. M., Pla, H., Fina, C., Carbó, A., Barretina-Ginesta, M. P., Martínez-Román, S., Carballas, E., González, A., Esteve, A., & Romeo, M. (2023). Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411420

Vancouver

Plaja A, Teruel I, Ochoa-de-Olza M, Cucurull M, Arroyo ÁJ, Pardo B, et al. Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411420

BibTeX
@article{Plaja2023,
  author = {Plaja, Andrea and Teruel, Iris and Ochoa-de-Olza, Maria and Cucurull, Marc and Arroyo, Álvaro Javier and Pardo, Beatriz and Ortiz, Irene and Gil-Martin, Marta and Piulats, Josep María and Pla, Helena and Fina, Claudia and Carbó, Anna and Barretina-Ginesta, Maria-Pilar and Martínez-Román, Sergio and Carballas, Elvira and González, Andrea and Esteve, Anna and Romeo, Margarita},
  title = {Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241411420}
}
Kostenlos starten →